# Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer

> **NCT00471120** · NA · TERMINATED · sponsor: **Dick Domanik** · enrollment: 20 (actual)

## Conditions studied

- Uterine Cancer
- Endometrial Cancer

## Interventions

- **OTHER:** P2x7 assay

## Key facts

- **NCT ID:** NCT00471120
- **Lead sponsor:** Dick Domanik
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-11
- **Primary completion:** 2007-04
- **Final completion:** 2008-02
- **Target enrollment:** 20 (ACTUAL)
- **Why stopped:** Study terminated due to protocol deficiencies.
- **Last updated:** 2015-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00471120

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00471120, "Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00471120. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*